We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation (AnPAF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01527279
Recruitment Status : Completed
First Posted : February 7, 2012
Last Update Posted : May 22, 2015
Information provided by (Responsible Party):
Institute of Cardiology, Warsaw, Poland

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2015
  Study Completion Date : March 2015